HOW TO READ AND USE THIS CHART

The chart shows the incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates observed in each age group, by registry, for selected cancer sites (individually or grouped), and in a specific time interval (individual years or grouped). The age specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).sAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+). per 100,000 person/years in each age group are reported separately for males, females, or both sexes together.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

The chart shows the time trends in incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates by ageAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+). over a specific time period, separately in each age group (and possibly sex) for selected cancer site(s). Each chart line corresponds to the age specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).sAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+). in the selected time period.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart reports overall incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. measures (number of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s or standardised rateThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population.sThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures.s) over a selected time period, enabling visualisation by sex and/or cancer site. The standardised rateThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population.sThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. can be computed using the World Standard Population, the old European Standard Population, or the new European Standard Population.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

The analysis of time trends of incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. considers three major factors: age of the subject at time of diagnosis or death (age), year the subject was born (birth/cohort), and year in which the subject was diagnosed or died (period).

By year of birth

The age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s are plotted against the years of birth - in intervals of five years - and stratified by age – in groups of 5 years. Each line describes the incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. rates of each age group by year of birth.

By year of diagnosis

The age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s are plotted against the years of diagnosis/death - in intervals of five years - and stratified by age – in groups of 5 years. Each line expresses the trend (increase or decrease) of incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference./mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rate in each 5 year age group by 5 year of time.

By age of diagnosis

The age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s are plotted against the age group of diagnosis - in intervals of five years - and stratified by year of birth – in groups of 5 years. Each line expresses the trend (increase or decrease) of incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. rate in each 5 year period of birth (cohort) by 5 year age groups.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. for the selected registry by year, in the selected time period. The visualised statistic are: number of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (Word standard population, old European Standard Population, new European Standard Population), and cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures..

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ THIS TYPE OF CHART

This chart plots data on incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. by cancer site for the selected registry, sex, and time period. Several statistics can be displayed: numbers of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s, age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (Word standard population, old European Standard Population, new European Standard Population), cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures.s. The cancer sites are ordered by decreasing value of the visualised statistic; if both incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. are selected, the sorting is done for incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference..

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ THIS TYPE OF TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. for the selected registry by cancer site. The visualised statistics are: number of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (Word standard population, old European Standard Population, new European Standard Population), and cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures..

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ THIS TYPE OF TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. for the selected registry by cancer site. The visualised statistics are: number of cases or deaths, age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s for the 5-year age groups selected by the user.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ THIS TYPE OF CHART

This chart plots data of incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. by registry for the selected cancer site, sex, and time period. Several statistics can be displayed: numbers of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.ss, age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (Word standard population, old European Standard Population, new European Standard Population), cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures.s. The registries are ordered by decreasing value of the visualised statistic; if both incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. are selected, the sorting is done for incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference..

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ THIS TYPE OF TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. for the selected cancer site by registry. The visualised statistics are: number of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (Word standard population, old European Standard Population, new European Standard Population), and cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures..

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

This map shows data on estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates by country/region for the selected cancer site, sex and age group.

The colours of the map refer to the categories of incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference./mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. measures, defined as the quintiles of the corresponding distribution.

The displayed statistics are age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised with old and new European Standard Population, and the World standard population.

Select the statistic you want to visualise from the corresponding icon enabling the choice of chart/table parameters.

Switching from the map to chart or table format is enabled by pressing the corresponding button on the top right of the chart/table.

The map, the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart shows data on estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates by country/region for the selected cancer site, sex and age group.

The displayed statistics are Age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised with old and new European Standard Population, and the World standard population, plus Cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures..

Select the statistic you want to visualise and the countries to be displayed from the corresponding parameters' icon enabling the choice of chart/table parameters.

Switching from the chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

The map, the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart compares data on estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. by sex. The available statistics are Age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised using the old and new European Standard Population, and the World Standard Population, plus Cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures..

The chart/table parameters' button allows the selection of the statistic and the selection of the sex to order the countries by decreasing values of the corresponding statistic and also the selection of the counties to be displayed (EU-27 or Europe).

Switching from chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

For a selected cancer site, sex and age group, this chart plots the relative change, by country/region, of estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference./mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates as compared to EU-27 values. The statistics used are age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised using the old and new European Standard Population, and the World Standard Population.

The chart/table parameters' button allows the selection of the statistic and the countries to be displayed (EU-27 or Europe) and the selection of the reference region used for the comparison (EU-27 or Europe).

Countries are ordered by decreasing value of the relative change for the selected statistic.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents data on estimated cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. by country/region, for the selected cancer site, sex and age group. The displayed statistics are number of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s, and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised with old and new European Standard Population and the World standard population, plus cumulative risk.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

This chart reports the total number of new cases and/or deaths for all cancers but non-melanoma skin cancer, plus the percentages of the 5 most common and deadliest cancers for the selected country/region, sex and age group. Each column of the chart is proportional to the contribution of each cancer on the total in the selected country/region, sex and age group.

HOW TO READ AND USE THIS CHART

This chart reports the percentage distribution of cancers for the selected country/region and sex in strata of age groups. Each slide of each bar of the chart is proportional to the contribution of each cancer on the total in the corresponding age group for the selected country/region, and sex. The chart shows the five most commonly diagnosed or the five deadliest cancer sites, while the rest of cancer sites are grouped in the “All other cancer sites” category.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart reports the percentage distribution of cancers for the selected country/region, sex and age group. Each slice of the pie is proportional to the contribution of each cancer on the total in the selected country/region, sex and age group.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart plots data on estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and/or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates by cancer site for the selected country/region, sex and age group. The statistics displayed are age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised with old and new European Standard Population, and the World Standard Population.

The chart/table parameters' button allows the selection of the statistic and of the reference population for the comparison.

The cancer sites are ordered by decreasing value of the statistic displayed; if both incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. and mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. are selected, the sorting is according to incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference..

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart compares data on estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. by sex. The available statistics are Age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised using the old and new European Standard Population, and the World Standard Population, plus Cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures..

The chart/table parameters' button allows the selection of the statistic and the selection of the sex to order the cancer sites by decreasing values of the corresponding statistic.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

For a selected country/region, sex and age group, this chart plots the relative change, by cancer site, of estimated incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference./mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. rates as compared to EU-27 values. The statistics displayed are age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised with old and new European Standard Population, and the World Standard Population.

The chart/table parameters' button allows the selection of the statistic and the selection of the reference region used for the comparison (EU-27 or Europe).

Cancer sites are ordered by decreasing value of the relative change for the selected statistic.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents data on estimated cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. or mortalityMortality is the number of deaths occurring in a given period in a specified population. It can be expressed as an absolute number of deaths per year or as a rate per 100,000 persons per year. by cancer site, for the selected country/region, sex and age group. The displayed statistics are number of cases or deaths, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s, and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., standardised with old and new European Standard Population and the World Standard Population, plus cumulative risk.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

This chart shows data on the relative change between incidence and/or mortality numbers estimated for the selected year (2025/30/35/40) and those for 2022, by projected population (baseline, lower fertility, lower mortality, lower migration, higher migration, no migration) for the selected country, cancer site, sex and age group.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

Switching from the chart to the table format is enabled by pressing the corresponding button on the top right of the chart/table.

The chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart shows the relative change (%) between incidence and/or mortality numbers estimated for the selected year (2025/30/35/40) and those for 2022, by projected population (baseline, lower fertility, lower mortality, lower migration, higher migration, no migration) in strata of age groups, for the selected country, cancer site and sex.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

Switching from the chart to the table format is enabled by pressing the corresponding button on the top right of the chart/table.

The chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

This table reports the number of new cancer cases (or cancer deaths), the corresponding populations and percentage changes (%) in 20XX compared to 2022 by projected population, for the selected country, sex and age group.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

The table can be ordered by each column and it can be exported in excel format

HOW TO READ AND USE THIS CHART

This chart reports the total number of new cancer cases and/or cancer deaths estimated for the selected year (2025/30/35/40) and for 2022 plus the corresponding relative change (%). The estimated numbers refer to the selected cancer site, sex, age group, and projected population.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

HOW TO READ AND USE THIS CHART

This map shows the relative change of incidence or mortality numbers estimated for the selected year (2025/30/35/40) and for 2022 by country, for the selected cancer site, sex, age group, and projected population.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂. The colours of the map refer to the categories of relative change, defined as the quintiles of the corresponding distribution.

Switching from the map to chart or table format is enabled by pressing the corresponding button on the top right of the chart/table.

The map, the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart compares the number of new cancer cases and/or cancer deaths estimated for the selected year (2025/30/35/40) with 2022 by country. Each point in the chart also displays the corresponding relative change (%) for each country, considering the selected cancer site, sex, age group, and projected population. Estimated numbers and corresponding relative changes (%) are displayed in the labels on the chart and are available in the table behind the chart.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

The chart/table parameters' button allows the selection of the countries to be displayed (EU-27 or EU-27+EFTA).

Switching from chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart presents the estimated relative change of cancer cases and/or cancer deaths from the selected year (2025/30/35/40) to 2022 by country, for the selected cancer site, age group, and projected population and compares the male and female relative changes if both sexes are selected. Estimated relative changes are displayed in the labels on the chart and are available in the table behind the chart.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

The chart/table parameters' button allows the selection of the sexes displayed (Group/Individual) and the selection of the countries to be displayed (EU-27 or EU-27+EFTA).

Switching from chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents the number of new cancer cases or cancer deaths estimated for the selected year (2025/30/35/40) and for 2022 with the corresponding populations and relative changes (%) by country, for the selected cancer site, sex, age group, and projected population.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

The chart/table parameters' button allows the selection of the countries to be displayed (EU-27 or EU-27+EFTA).

The table can be ordered by each column, and it can be exported in excel format

HOW TO READ AND USE THIS CHART

This chart reports the total number of new cancer cases and/or cancer deaths estimated for the selected year (2025/30/35/40) for each sex, plus the percentages of the 5 most common and/or deadliest cancers in the selected year and in 2022. Each column of the chart is proportional to the contribution of each cancer on the total for the selected country, sex, age group and projected population.

HOW TO READ AND USE THIS CHART

This chart reports the percentage distribution of cancers for the selected country, sex and projected population in strata of age groups. Each slide of each bar of the chart is proportional to the contribution of each cancer on the total in the corresponding age group. The chart shows the five most commonly diagnosed or the five deadliest cancer sites, while the rest of cancer entities are grouped in the “All other cancer sites” category.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart compares the number of new cancer cases and/or cancer deaths estimated for 2022 and for the selected year by cancer. Each point in the chart also displays (on mouse over) the corresponding relative change (%) for the selected country, sex, age group and projected population.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

Switching from chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart compares the number of new cancer cases and/or cancer deaths estimated for 2022 and for the selected year by cancer. Each point in the chart also displays (om mouse over) the corresponding relative change (%) for the selected country, sex, age group and projected population.

The relative change is calculated from the estimated numbers of new cancer cases or cancer deaths for the selected year and for year 2022: (N_year-N₂₀₂₂)/N₂₀₂₂.

Switching from chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

HOW TO READ AND USE THIS CHART

This chart reports the number of new cancer cases (and/or cancer deaths) by year, for the selected country, sex, age group, and projected population.

The chart/table parameters' button allows to select the visualisation modality by sex (individual/grouped).

Switching from chart to table format is enabled by pressing the corresponding icon on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

The chart shows age-specific incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. rates observed in each age group, by diagnostic group (separately or grouped), year of diagnosis (separately or grouped), and sex (males and females separately or together). The incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s (expressed per 1,000,000) are measured along the vertical axis and the age groups appear on the horizontal axis.

If more than one sex, diagnostic group, or year is selected, the user can visualise the incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. rates grouping together the two sexes, diagnostic groups, or the years selected. The age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s can be displayed in the standard or in the logarithmic scale.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart reports overall incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. measures (number of cases, crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s or standardised rateThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population.sThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population., cumulative riskCumulative incidence/mortality is the probability or risk of individuals getting/dying from the disease over a specified age-span. Cumulative risk is expressed as the number of cases/deaths per 1000 person-years that are expected to occur in a given population between the specified age limits (e.g. between birth and the age 84 years) if the cancer rates were as those observed in the specified time period in the absence of competing causes. Like the age-standardised rate, cumulative risk permits comparing between populations of different age structures.s) over a selected time period (grouped by 3 years time frames), enabling visualisation by registry and/or diagnostic group. The standardised rateThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population.sThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. can be computed using the World Standard Population, the old European Standard Population, or the new European Standard Population.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. by diagnostic subgroup, for the selected region, diagnostic group, sex and time period. The displayed statistics are number of cases, percentages, age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s (missing only if we decide to display this table).

The table can be sorted according to each column field in ascending or descending order by clicking on the corresponding arrows, and it can be exported in excel format.

HOW TO READ AND USE THIS TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. by diagnostic subgroup, for the selected region, diagnostic group, sex and time period. The displayed statistics are crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s, and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (World Standard Population, old or new European Standard Population).

The table can be sorted according to each column field in ascending or descending order by clicking on the corresponding arrows, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

This chart reports the percentage distribution of diagnostic groups for the selected region, sex and time period in terms of the number of new cases (incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference.).

This data can also be visualised in table format. Both the chart and the table can be exported in pdf or excel format respectively.

HOW TO READ AND USE THIS TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. by diagnostic group and subgroup, for the selected region, sex and time period. The displayed statistics are number of cases and percentages.

The table can be sorted according to each column field in ascending or descending order by clicking on the corresponding arrows, and it can be exported in excel format.

HOW TO READ AND USE THIS TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. by diagnostic subgroup, for the selected region, diagnostic group, sex and time period. The displayed statistics are crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s, and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (World Standard Population, old or new European Standard Population).

The table can be sorted according to each column field in ascending or descending order by clicking on the corresponding arrows, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

The chart shows age-specific incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. rates observed in each age group, by diagnostic group (separately or grouped), year of diagnosis (separately or grouped), and sex (males and females separately or together). The incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s (expressed per 1,000,000) are measured along the vertical axis and the age groups appear on the horizontal axis.

If more than one sex, diagnostic group, or year is selected, the user can visualise the incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. rates grouping together the two sexes, diagnostic groups, or the years selected. The age-specific rateAn age-specific rate is the incidence or mortality rate for a specified age group, in which the numerator and denominator refer to the same age group; it is expressed as the number of new cancer cases or deaths per 100,000 population at risk. Five-year age categories are normally used (highest group 85+).s can be displayed in the standard or in the logarithmic scale. This data can also be visualised in table format.

HOW TO READ AND USE THIS TABLE

The table presents data on cancer incidenceIncidence is the number of new cases arising in a given period in a specified population. This information is collected routinely by cancer registries. It can be expressed as an absolute number of cases per year or as a rate per 100,000 persons per year (see age-specific rate and rate above). The rate provides an approximation of the average risk of developing a cancer in a population for the time period of reference. by diagnostic subgroup, for the selected region, diagnostic group, sex and time period. The displayed statistics are crudeThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk. rateThe crude rate is the ratio of the number of new cases or deaths in a specified population and time period to the size of the population at risk during the same time period. Incidence and mortality rate are usually presented as an annual rate per 100,000 persons at risk.s, and age-adjusted ratesThe ASR is a weighted mean of the age-specific rates where the weights are taken from the population distribution of a standard population; the ASR is expressed per 100,000. Comparison of rates referring to different time periods or different geographical areas is only possible after considering the differences in the age structure of the underlying populations. The age-standardisation allows the comparison of the rates that are arithmetically adjusted to have the same age structure of the standard population. The standard population used in the ECIS are the following old European Standard Population, new European Standard Population, and World Standard Population. (World Standard Population, old or new European Standard Population).

The table can be sorted according to each column field in ascending or descending order by clicking on the corresponding arrows, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

This chart plots data from the population for the country selected by sex. The population refers to the last available year for this country. In countries where a national registry is not available, the data on population are obtained by averaging the populations of the areas (registries) currently contributing to the ENCR-JRC project and included in this analysis.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This table plots data from the population for the country selected by sex. The population refers to the last available year for this country. In countries where a national registry is not available, the data on population are obtained by averaging the populations of the areas (registries) currently contributing to the ENCR-JRC project and included in this analysis.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This table plots data from the population for the country selected by sex. The population refers to the last available year for this country. In countries where a national registry is not available, the data on population are obtained by averaging the populations of the areas (registries) currently contributing to the ENCR-JRC project and included in this analysis.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This map shows estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by country for the selected sex, cancer entity, attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date and number of years from diagnosis (complete or limited duration prevalence).

The displayed statistics are crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). or age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative prevalence proportions (per 100,000). Age-adjusted proportions are available only when selecting All ages and are standardised with the 2013 European Standard Population.

The colours of the map refer to the categories of prevalence measures, defined as the quintiles of the corresponding distribution.

Select the statistic you want to visualise from the corresponding icon enabling the choice of chart/table parameters. Switching from the map to chart or table format is enabled by pressing the corresponding button on the top right of the chart/table. The map, the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This bar chart shows estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 for the selected sex, cancer entity, attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date and number of years from diagnosis (complete or limited duration prevalence).

The displayed statistics are crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). or age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative prevalence proportions (per 100,000). Age-adjusted proportions are available only when selecting All ages and are standardised with the 2013 European Standard Population.

Select the statistic you want to visualise from the corresponding icon enabling the choice of chart/table parameters. Switching from the chart to table format is enabled by pressing the corresponding button on the top right of the chart/table. The chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents population size and estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 for the selected cancer entity, sex, attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date and number of years from diagnosis (complete or limited duration prevalence).

The displayed statistics are the cumulative number of prevalent cases, the crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). and age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative proportions of prevalent cases (per 100,000). Age-adjusted proportions are available only when selecting All ages and are standardised with the 2013 European Standard Population.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

This chart reports estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex and attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date. The displayed statistics are the number of prevalent cases for all sites (i.e. all cancers combined) and the percent distribution of the top five highest prevalence cancers.

Percent distribution is obtained dividing cancer-specific prevalence counts by the sum of all cancer-specific prevalence counts. Please note that people with multiple primary cancersPrevalence estimates are person-based prevalence estimates. This means that people diagnosed with multiple primary cancers are counted only once when computing estimates for all cancers combined (all sites) and, conversely, they are counted more than once when computing cancer-specific estimates, because they contribute to the prevalence counts of each primary cancer. As a consequence, the sum of all cancer-specific prevalence counts is by definition higher than the prevalence count for all cancers combined. contribute to more than one cancer specific estimate. Consequently, the sum of all cancer-specific prevalence counts is higher than the prevalence count for all sites.

HOW TO READ AND USE THIS CHART

This chart reports the percent distribution of prevalent cases at 01/01/2020 for the top 9 highest prevalence cancers, plus all other cancers, for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex and attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date.

Percent distribution is obtained dividing cancer-specific prevalence counts by the sum of all cancer-specific prevalence counts. Please note that people with multiple primary cancersPrevalence estimates are person-based prevalence estimates. This means that people diagnosed with multiple primary cancers are counted only once when computing estimates for all cancers combined (all sites) and, conversely, they are counted more than once when computing cancer-specific estimates, because they contribute to the prevalence counts of each primary cancer. As a consequence, the sum of all cancer-specific prevalence counts is by definition higher than the prevalence count for all cancers combined. contribute to more than one cancer specific estimate. Consequently, the sum of all cancer-specific prevalence counts is higher than the prevalence count for all sites.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table. Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart reports the percent distribution of prevalent cases at 01/01/2020 for the top 9 highest prevalence cancers, plus all other cancers, for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex and attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date.

Percent distribution is obtained dividing cancer-specific prevalence counts by the sum of all cancer-specific prevalence counts. Please note that people with multiple primary cancersPrevalence estimates are person-based prevalence estimates. This means that people diagnosed with multiple primary cancers are counted only once when computing estimates for all cancers combined (all sites) and, conversely, they are counted more than once when computing cancer-specific estimates, because they contribute to the prevalence counts of each primary cancer. As a consequence, the sum of all cancer-specific prevalence counts is by definition higher than the prevalence count for all cancers combined. contribute to more than one cancer specific estimate. Consequently, the sum of all cancer-specific prevalence counts is higher than the prevalence count for all sites.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table. Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart plots estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by cancer entity for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex, attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date and number of years from diagnosis (complete or limited duration prevalence). The statistics displayed are the crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). or age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative proportions of prevalent cases (per 100,000). Age-adjusted proportions are available only when selecting All ages and are standardised with the 2013 European Standard Population.

The chart/table parameters' button allows the selection of the statistic and of the reference population for the comparison.

Cancer entities are ordered by decreasing value of the statistic displayed.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

This chart compares estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more cancer entity and sex for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date and number of years from diagnosis (complete and limited duration prevalence). The available statistics are the crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). or age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative proportion of prevalent cases (per 100,000). Age-adjusted proportions are available only when selecting All ages and are standardised using the 2013 European Standard Population.

The chart/table parameters' button allows the selection of the statistic and the selection of the sex to order the cancer sites by decreasing values of the corresponding statistic.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

For the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex and attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date, this chart plots the difference between estimated country-specific prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 and the corresponding EU-27 or European pool values by cancer entity. The statistics displayed are the absolute differences between crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). or age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative proportions (per 100,000). The difference between age-adjusted proportions is available only when selecting All ages and is standardised with the 2013 European Standard Population.

The chart/table parameters' button allows the selection of the statistic and the selection of the reference region used for the comparison (EU-27 or European pool).

Cancer entities are ordered by decreasing value of the relative change for the selected statistic.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more by cancer entity at 01/01/2020 for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex, attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date and number of years from diagnosis (complete or limited duration prevalence). The displayed statistics are the cumulative number of prevalent cases and the crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). or age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. cumulative proportions of prevalent cases (per 100,000). Age-adjusted proportions of prevalent cases are available only when selecting All ages and is standardised with the 2013 European Standard Population.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

The chart shows estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , cancer entity and number of years from diagnosis (complete or limited duration prevalence). The displayed statistic is the crude cumulative proportion of prevalent cases (per 100,000).

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table. Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

The chart shows age-specific estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by number of years from diagnosis (complete or limited duration prevalence) for the selected sex, cancer entity and country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 . The displayed statistic is the crude cumulative proportion of prevalent cases (per 100,000).

Each line reported in the chart represents a specific age group for the specific sex/cancer/country.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table. Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

The chart presents estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more by index date (1st of January 2010, 2015 and 2020) for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex, cancer entity and attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed.date. The displayed statistic is the cumulative number of prevalent cases by disease duration (5 years, 10 years, all years).

Each bar is divided in three distinct intervals with three different colours (0-5, 5-10 and 10+ years from diagnosis). On the bars, the percentage of interval-specific prevalent cases out of the total (%) is reported for each interval. Moving the mouse over the bar, the interval-specific number of prevalent cases is displayed for each interval.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table. Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table presents population size and estimated prevalencePrevalence is the number or proportion of people in a specified population who live after a cancer diagnosis at a certain point in time (index date). Read more at 01/01/2020 by attained age at prevalenceAge at prevalence is the age of prevalent cases at the prevalence index date. It differs from the age at diagnosis and is the age attained by prevalent cases on the index date in which prevalence is computed. date for the selected country or European areaPrevalence estimates in the EUROCARE-6 study are provided by grouping countries' estimates according to the following European areas: NORTHERN EUROPE: Denmark, Finland, Iceland, Norway, Sweden / UK AND IRELAND: Ireland, UK-England, UK-Northern Ireland, UK-Scotland, UK-Wales / CENTRAL EUROPE: Austria, Belgium, France, Germany, Switzerland, Netherlands / SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain / EASTERN EUROPE: Bulgaria, Czechia, Estonia, Latvia, Lithuania, Poland, Slovakia / EUROPEAN POOL OF REGISTRIES: all above 29 countries / EU-27 , sex, cancer entity and number of years from diagnosis (complete or limited duration prevalence). The displayed statistics are the cumulative number of prevalent cases and the cumulative crudeThe crude prevalence proportion (or crude proportion of prevalent cases) is the ratio of the number of prevalent cases in a specified population to the size of the population at a given date (prevalence index date). Crude prevalence proportions reflect the real burden of the disease in a population and are relevant for health care programming. Prevalence proportion is generally presented as proportion per 100,000 inhabitants or as percent proportion (%). and age-adjustedThe Age-standardised (or age-adjusted) prevalence proportion is the weighted mean of all age-specific crude prevalence proportions. The weights used in the ECIS are taken from the 2013 European Standard Population. Age-standardised prevalence proportions allow comparisons over time or between populations, which are adjusted for varying age-structure of the population. proportions of prevalent cases (per 100,000). Age-adjusted proportions are available only when selecting All ages and are standardised with the 2013 European Standard Population.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

The chart shows the five-year observed survival and relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. (%) for adult (15 years and over) patients diagnosed in years 2000-2007 with the selected cancer in the selected country or European area. The vertical axis reports 5-year survival figures (expressed in percentage) and the horizontal axis reports the age at diagnosis. Each line reported in the chart represents one country and one cancer site.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS CHART

The chart shows the age-specific and age-standardised observed survival and relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. at different follow-up intervals for adult (15 years and over) patients diagnosed in years 2000-2007 with the selected cancer in the selected countries or European areas. European average figures are population-weighted averages of the country-specific relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. estimates. The vertical axis reports relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. (expressed in percentage) and the horizontal axis reports the follow-up intervals. Each line reported in the chart represents a specific age group/cancer site/country.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table shows the number of adult (15 years and over) patients diagnosed in 2000-2007 with the selected cancer in the selected country and the observed survival and relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. at one, three, and five years after diagnosis. The number of cases and the survival are expressed by age groups at diagnosis, and for all adult ages together. The observed survival and relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. estimates for all adults are age-standardised. Age standardisation is made with the direct method using cancer-specific weightings obtained from the International Cancer Survival Standards (ICSS).

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

The chart shows the relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. at five years after diagnosis for adult (15 years and over) patients diagnosed in 2000-2007 with the selected cancer by country. Each blue bar corresponds to the survival estimate of each European country, while orange and orange bordered bars refer respectively to Europe as a whole and to the European areas: Northern Europe, UK and Ireland, Central Europe, Southern Europe and Eastern Europe. Relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. for Europe is computed as the weighted average of country-specific survival estimates. All relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. estimates refer to all adult ages and they are age-standardised. Age standardisation is made with the direct method using cancer-specific weightings obtained from the International Cancer Survival Standards (ICSS). The survival estimate of all sites, but non-melanoma skin cancer, is also cancer site case-mix standardised.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

HOW TO READ AND USE THIS TABLE

The table reports the number of adult patients (15 years and over) diagnosed in 2000-2007 with the selected cancer, and the age-standardised relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. at one and five years after diagnosis by European country and area (Northern Europe, UK and Ireland, Central Europe, Southern Europe, Eastern Europe, and Europe as a whole). Relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. for Europe is computed as the weighted average of country-specific survival estimates. The relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. estimates refer to all adult ages and they are age-standardised. Age standardisation is made with the direct method using cancer-specific weightings obtained from the International Cancer Survival Standards (ICSS). The survival estimates of all sites but non-melanoma skin cancer are also cancer site case-mix standardised.

The table can be ordered by each column, and it can be exported in excel format.

HOW TO READ AND USE THIS CHART

The chart shows the relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. at five years after diagnosis for adult (15 years and over) patients diagnosed in 2000-2007 with the selected cancer by country. Each blue bar corresponds to the survival estimate of each European country, while orange and orange bordered bars refer respectively to Europe as a whole and to the European areas: Northern Europe, UK and Ireland, Central Europe, Southern Europe and Eastern Europe. Relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. for Europe is computed as the weighted average of country-specific survival estimates. All relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. estimates refer to all adult ages and they are age-standardised. Age standardisation is made with the direct method using cancer-specific weightings obtained from the International Cancer Survival Standards (ICSS). The survival estimate of all sites, but non-melanoma skin cancer, is also cancer site case-mix standardised.

Switching from chart to table format is enabled by pressing the corresponding button on the top right of the chart/table.

Both the chart and the table can be exported in pdf, png, jpeg or excel format, respectively.

European regions are defined as following:

• NORTHERN EUROPE: Denmark; Finland; Iceland; Norway; Sweden
• UK AND IRELAND: Ireland; UK, England; UK, Northern Ireland; UK, Scotland; UK, Wales
• CENTRAL EUROPE: Austria; Belgium; France; Germany; Switzerland; The Netherlands
• SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain
• EASTERN EUROPE: Bulgaria, Czech Republic, Estonia, Latvia, Lithuania, Poland, Slovakia

HOW TO READ AND USE THIS TABLE

The table reports the number of adult patients (15 years and over) diagnosed in 2000-2007 with the selected cancer, and the age-standardised relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. at one and five years after diagnosis by European country and area (Northern Europe, UK and Ireland, Central Europe, Southern Europe, Eastern Europe, and Europe as a whole). Relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. for Europe is computed as the weighted average of country-specific survival estimates. The relative survivalThe relative survival is a standard indicator for comparing cancer survival in population-based studies when the underlying cause of death in unknown. Relative survival is the ratio of the observed survival of patients to the expected survival in a comparable group in the general population for the same region, age, sex and calendar year. It can be interpreted as the survival probability of cancer patients in the absence of other causes of death, which can vary widely between countries. In the EUROCARE-5 study the expected survival was estimated by the Ederer II method from the lifetables of all causes mortality by age, sex, cancer registry and calendar year. Relative survival of patients diagnosed in 2000-2007 and followed up to 2008 was estimated using the classic cohort approach. Relative survival was standardised by age using the International Cancer Survival Standards (ICSS). The mean European relative survival was estimated by weighting country-specific relative survival by the country population. estimates refer to all adult ages and they are age-standardised. Age standardisation is made with the direct method using cancer-specific weightings obtained from the International Cancer Survival Standards (ICSS). The survival estimates of all sites but non-melanoma skin cancer are also cancer site case-mix standardised.

The table can be ordered by each column, and it can be exported in excel format.

European regions are defined as following:

• NORTHERN EUROPE: Denmark; Finland; Iceland; Norway; Sweden
• UK AND IRELAND: Ireland; UK, England; UK, Northern Ireland; UK, Scotland; UK, Wales
• CENTRAL EUROPE: Austria; Belgium; France; Germany; Switzerland; The Netherlands
• SOUTHERN EUROPE: Croatia, Italy, Malta, Portugal, Slovenia, Spain
• EASTERN EUROPE: Bulgaria, Czech Republic, Estonia, Latvia, Lithuania, Poland, Slovakia